205 related articles for article (PubMed ID: 26298056)
1. Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain.
Takenouchi A; Saito K; Saito E; Saito T; Hishiki T; Matsunaga T; Isegawa N; Yoshida H; Ohnuma N; Shirasawa H
Pediatr Surg Int; 2015 Dec; 31(12):1151-9. PubMed ID: 26298056
[TBL] [Abstract][Full Text] [Related]
2. Sindbis viral structural protein cytotoxicity on human neuroblastoma cells.
Saito EY; Saito K; Hishiki T; Takenouchi A; Saito T; Sato Y; Terui K; Matsunaga T; Shirasawa H; Yoshida H
Pediatr Surg Int; 2020 Oct; 36(10):1173-1180. PubMed ID: 32696122
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain.
Unno Y; Shino Y; Kondo F; Igarashi N; Wang G; Shimura R; Yamaguchi T; Asano T; Saisho H; Sekiya S; Shirasawa H
Clin Cancer Res; 2005 Jun; 11(12):4553-60. PubMed ID: 15958641
[TBL] [Abstract][Full Text] [Related]
4. Engineered measles virus Edmonston strain used as a novel oncolytic viral system against human neuroblastoma through a CD46 and nectin 4-independent pathway.
Zhang SC; Cai WS; Zhang Y; Jiang KL; Zhang KR; Wang WL
Cancer Lett; 2012 Dec; 325(2):227-37. PubMed ID: 22796607
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
6. Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors.
Lun X; Ruan Y; Jayanthan A; Liu DJ; Singh A; Trippett T; Bell J; Forsyth P; Johnston RN; Narendran A
Mol Oncol; 2013 Oct; 7(5):944-54. PubMed ID: 23816608
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells.
Saito K; Uzawa K; Kasamatsu A; Shinozuka K; Sakuma K; Yamatoji M; Shiiba M; Shino Y; Shirasawa H; Tanzawa H
Br J Cancer; 2009 Aug; 101(4):684-90. PubMed ID: 19638980
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
[TBL] [Abstract][Full Text] [Related]
9. PKR-NF-κB Pathway Upstream of IFN-β Induction Is Dysregulated in Oncolytic Sindbis Virus-infected HeLa Cells.
Ma X; Ogawa T; Tian Z; Yi R; Tang K; Saito K; Yatabe S; Ohno Y; Muroyama R; Ido E; Matsubara H; Shirasawa H
Anticancer Res; 2023 Jul; 43(7):2923-2932. PubMed ID: 37351990
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic poliovirus therapy and immunization with poliovirus-infected cell lysate induces potent antitumor immunity against neuroblastoma in vivo.
Toyoda H; Wimmer E; Cello J
Int J Oncol; 2011 Jan; 38(1):81-7. PubMed ID: 21109928
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic virotherapy for neuroblastoma.
Ramírez M; García-Castro J; Alemany R
Discov Med; 2010 Nov; 10(54):387-93. PubMed ID: 21122470
[TBL] [Abstract][Full Text] [Related]
12. Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor.
Tseng JC; Granot T; DiGiacomo V; Levin B; Meruelo D
Cancer Gene Ther; 2010 Apr; 17(4):244-55. PubMed ID: 19798121
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
[TBL] [Abstract][Full Text] [Related]
14. Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes.
McKnight KL; Simpson DA; Lin SC; Knott TA; Polo JM; Pence DF; Johannsen DB; Heidner HW; Davis NL; Johnston RE
J Virol; 1996 Mar; 70(3):1981-9. PubMed ID: 8627724
[TBL] [Abstract][Full Text] [Related]
15. Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.
Mahller YY; Vaikunth SS; Ripberger MC; Baird WH; Saeki Y; Cancelas JA; Crombleholme TM; Cripe TP
Cancer Res; 2008 Feb; 68(4):1170-9. PubMed ID: 18281493
[TBL] [Abstract][Full Text] [Related]
16. Sindbis Virus Infection Causes Cell Death by nsP2-Induced Transcriptional Shutoff or by nsP3-Dependent Translational Shutoff.
Akhrymuk I; Frolov I; Frolova EI
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232189
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
[TBL] [Abstract][Full Text] [Related]
18. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
Tanos R; Karmali D; Nalluri S; Goldsmith KC
BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus.
Sun K; Shi X; Li L; Nie X; Xu L; Jia F; Xu F
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835433
[TBL] [Abstract][Full Text] [Related]
20. 13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma.
Nomura M; Shimbo T; Miyamoto Y; Fukuzawa M; Kaneda Y
Cancer Sci; 2013 Feb; 104(2):238-44. PubMed ID: 23134437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
